Gerresheimer (ETR:GXI) PT Set at €109.00 by Berenberg Bank

Gerresheimer (ETR:GXI) has been given a €109.00 ($128.24) target price by research analysts at Berenberg Bank in a research report issued on Friday, Borsen Zeitung reports. Berenberg Bank’s price target suggests a potential upside of 40.28% from the stock’s previous close.

A number of other equities analysts have also recently weighed in on GXI. Deutsche Bank Aktiengesellschaft set a €112.00 ($131.76) price target on Gerresheimer in a report on Friday, September 17th. JPMorgan Chase & Co. set a €86.20 ($101.41) price target on Gerresheimer in a report on Thursday, October 14th. Credit Suisse Group set a €100.00 ($117.65) price target on Gerresheimer in a report on Tuesday, October 12th. Finally, The Goldman Sachs Group set a €111.00 ($130.59) price target on Gerresheimer in a report on Tuesday, October 12th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Gerresheimer presently has a consensus rating of “Hold” and an average target price of €98.31 ($115.66).

ETR GXI opened at €77.70 ($91.41) on Friday. The stock has a market cap of $2.44 billion and a PE ratio of 28.14. Gerresheimer has a fifty-two week low of €75.60 ($88.94) and a fifty-two week high of €103.70 ($122.00). The business has a 50 day moving average price of €86.67 and a two-hundred day moving average price of €89.00. The company has a quick ratio of 0.54, a current ratio of 0.93 and a debt-to-equity ratio of 124.92.

About Gerresheimer

Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices.

Featured Article: What is an Initial Coin Offering (ICO)?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.